H-Asn(GlcNAc-β-D)-OH |
Catalog No.GA22100 |
Levels of aspartylglucosamine (AADG), a glycoprotein degradation product, in urine are increased in case of aspartylglucosaminuria, a lysosomal storage disease caused by deficient activity of glycosylasparaginase and characterized by motor and mental retardation.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2776-93-4
Sample solution is provided at 25 µL, 10mM.
Levels of aspartylglucosamine (AADG), a glycoprotein degradation product, in urine are increased in case of aspartylglucosaminuria, a lysosomal storage disease caused by deficient activity of glycosylasparaginase and characterized by motor and mental r
Average Rating: 5
(Based on Reviews and 40 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *